BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26909598)

  • 1. Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression.
    Cianfrocca R; Tocci P; Rosanò L; Caprara V; Sestito R; Di Castro V; Bagnato A
    Oncotarget; 2016 Apr; 7(14):17790-804. PubMed ID: 26909598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling.
    Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Spadaro F; Salvati E; Biroccio AM; Natali PG; Bagnato A
    Oncogene; 2013 Oct; 32(42):5066-77. PubMed ID: 23208497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells.
    Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L
    Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy.
    Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A
    Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.
    Di Modugno F; Caprara V; Chellini L; Tocci P; Spadaro F; Ferrandina G; Sacconi A; Blandino G; Nisticò P; Bagnato A; Rosanò L
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3132-3137. PubMed ID: 29439204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer.
    Chellini L; Caprara V; Spadaro F; Sestito R; Bagnato A; Rosanò L
    Matrix Biol; 2019 Aug; 81():17-33. PubMed ID: 30367951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.
    Tocci P; Cianfrocca R; Di Castro V; Rosanò L; Sacconi A; Donzelli S; Bonfiglio S; Bucci G; Vizza E; Ferrandina G; Scambia G; Tonon G; Blandino G; Bagnato A
    Nat Commun; 2019 Jul; 10(1):3196. PubMed ID: 31324767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway.
    Guo QY; Song JN; Chen YM; Yuan HN; Xue WS; Sun Y; Niu XL; Wang Y; Chen X
    Med Oncol; 2024 May; 41(6):155. PubMed ID: 38744773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.
    Spinella F; Rosanò L; Del Duca M; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    PLoS One; 2010 Jun; 5(6):e11241. PubMed ID: 20574527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
    Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
    Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.
    Ji F; Wang Y; Qiu L; Li S; Zhu J; Liang Z; Wan Y; Di W
    Int J Oncol; 2013 May; 42(5):1578-88. PubMed ID: 23545606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer.
    Masi I; Ottavi F; Del Rio D; Caprara V; Vastarelli C; Giannitelli SM; Fianco G; Mozetic P; Buttarelli M; Ferrandina G; Scambia G; Gallo D; Rainer A; Bagnato A; Spadaro F; Rosanò L
    Cell Death Dis; 2023 Jan; 14(1):73. PubMed ID: 36717550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
    Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
    Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Zhang Y; Xu Y; Ma J; Pang X; Dong M
    Sci Rep; 2017 Jan; 7():40524. PubMed ID: 28091613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression.
    Shenoy SK; Han S; Zhao YL; Hara MR; Oliver T; Cao Y; Dewhirst MW
    Oncogene; 2012 Jan; 31(3):282-92. PubMed ID: 21685944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer.
    Cianfrocca R; Rosanò L; Tocci P; Sestito R; Caprara V; Di Castro V; De Maria R; Bagnato A
    Cell Death Differ; 2017 Oct; 24(10):1811-1820. PubMed ID: 28708138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancer.
    Tocci P; Caprara V; Cianfrocca R; Sestito R; Di Castro V; Bagnato A; Rosanò L
    Life Sci; 2016 Aug; 159():49-54. PubMed ID: 26776837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNAIL gene inhibited by hypoxia-inducible factor 1α (HIF-1α) in epithelial ovarian cancer.
    Zhang P; Liu Y; Feng Y; Gao S
    Int J Immunopathol Pharmacol; 2016 Sep; 29(3):364-75. PubMed ID: 27044634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Natali PG; Bagnato A
    J Biol Chem; 2002 Aug; 277(31):27850-5. PubMed ID: 12023962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathway.
    Wang Y; Ma J; Shen H; Wang C; Sun Y; Howell SB; Lin X
    Oncol Rep; 2014 Nov; 32(5):2150-8. PubMed ID: 25174950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.